Press release from Companies: DanCann Pharma A/S: A strengthened market position after an impressive H2-2022

Press release from Companies: DanCann Pharma A/S: CannGros ApS’ new facilities in Ansager have been approved by the Danish Medicines Agency for import, repackaging and distribution

Press release from Companies: DanCann Pharma A/S: The US will enable more research into medical cannabis

Press release from Companies: DanCann Pharma A/S’ shares commence trading on the OTCQB venture market in the United States

Press release from Companies: DanCann Pharma A/S receives EU-GMP certification for its manufacturing facility Biotech Pharm1

Market Notices: Market Notice 207/22– Last day of trading in DanCann Pharma A/S BTU

Press release from Companies: DanCann Pharma A/S announces last day for trading in BTU and the first day of trading in the warrants of series TO 2

Press release from Companies: DanCann Pharma A/S announces outcome of the Rights Issue

Press release from Companies: DanCann Pharma A/S: A strong and growing organization is ready to fulfill the commercial ambitions

Press release from Companies: Last day of subscription of units in DanCann Pharma A/S ongoing rights issue and guidance on how to subscribe

Press release from Companies: DanCann Pharma A/S with inspection by the Danish Medicine Agency during Q4-2022: expects to get EU-GMP approval before end-2022

Press release from Companies: DanCann Pharma A/S’ Board of Directors and Management have subscribed for units in the ongoing Rights Issue